Modafinil in the treatment of excessive sleepiness

The wake-promoting agent modafinil is approved for the treatment of excessive sleepiness associated with obstructive sleep apnea (OSA), shift work disorder (SWD), and narcolepsy. In OSA, modafinil is recommended for use as an adjunct to standard therapies that treat the underlying airway obstruction...

Descripción completa

Detalles Bibliográficos
Autor principal: Schwartz, Jonathan RL
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761173/
https://www.ncbi.nlm.nih.gov/pubmed/19920895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761173/
https://www.ncbi.nlm.nih.gov/pubmed/19920895

Ejemplares similares